Evidence map›Paper›PMID 35480790›Full record

ArticleRSC advances2021

Discrimination between sialic acid linkage modes using sialyllactose-imprinted polymers.

Liliia Mavliutova, Bruna Munoz Aldeguer, Jesper Wiklander, Celina Wierzbicka, Chau Minh Huynh, Ian A Nicholls, Knut Irgum, Börje Sellergren

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Liliia MavliutovaDepartment of Biomedical Sciences, Faculty of Health and Society, Malmö University SE-20506 Malmö Sweden borje.sellergren@mau.se.
Bruna Munoz AldeguerDepartment of Biomedical Sciences, Faculty of Health and Society, Malmö University SE-20506 Malmö Sweden borje.sellergren@mau.se.
Jesper WiklanderBioorganic and Biophysical Chemistry Laboratory, Linnaeus University Centre for Biomaterials Chemistry, Department of Chemistry and Biomedical Sciences, Linnaeus University 391 82 Kalmar Sweden.ORCID https://orcid.org/0000-0002-2042-4818
Celina WierzbickaDepartment of Biomedical Sciences, Faculty of Health and Society, Malmö University SE-20506 Malmö Sweden borje.sellergren@mau.se.
Chau Minh HuynhDepartment of Chemistry, Umeå University 901 87 Umeå Sweden.ORCID https://orcid.org/0000-0001-8883-607X
Ian A NichollsBioorganic and Biophysical Chemistry Laboratory, Linnaeus University Centre for Biomaterials Chemistry, Department of Chemistry and Biomedical Sciences, Linnaeus University 391 82 Kalmar Sweden.ORCID https://orcid.org/0000-0002-0407-6542
Knut IrgumDepartment of Chemistry, Umeå University 901 87 Umeå Sweden.
Börje SellergrenDepartment of Biomedical Sciences, Faculty of Health and Society, Malmö University SE-20506 Malmö Sweden borje.sellergren@mau.se.ORCID https://orcid.org/0000-0002-2392-3305
Malmö University · SELinnaeus University · SEUmeå University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glycosylation plays an important role in various pathological processes such as cancer. One key alteration in the glycosylation pattern correlated with cancer progression is an increased level as well as changes in the type of sialylation. Developing molecularly-imprinted polymers (MIPs) with high affinity for sialic acid able to distinguish different glycoforms such as sialic acid linkages is an important task which can help in early cancer diagnosis. Sialyllactose with α2,6'

Identifiers

PMID35480790
PMCPMC9034230
OpenAlexW3176763530

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.